Unmasking the secrets of meningioma: A slow but rewarding journey

Surgical Neurology

Volumn 61, Issue 2, 2004, Pages 171-173

  Perry, Arie ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MERLIN; PROTEIN P16;

ADJUVANT THERAPY; BENIGN TUMOR; CENTRAL NERVOUS SYSTEM; CHROMOSOME 10; CHROMOSOME 14Q; CHROMOSOME 17Q; CHROMOSOME 1P; CHROMOSOME 20Q; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME 3P; CHROMOSOME 6Q; CHROMOSOME 9P; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DNA MICROARRAY; EDITORIAL; GENE MUTATION; GENETICS; HISTOLOGY; HUMAN; HYPEROSTOSIS; MENINGIOMA; MOLECULAR BIOLOGY; MORBIDITY; MORTALITY; NEURILEMOMA; NEUROFIBROMATOSIS; NEUROSURGERY; ONCOLOGY; PATHOLOGY; PHYSIOLOGY; RADIATION; SCHWANN CELL; SCREENING; TUMOR SUPPRESSOR GENE;

EID: 0742272463     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(03)00488-9     Document Type: Editorial

References (15)

1. Akutsu H, Sugita K, Sonobe M, Matsumura A. Parasagittal meningioma en plaque with extracranial extension presenting diffuse massive hyperostosis of the skull. Surg Neurol 2003;61:165-70.
2. INK4c) in atypical and anaplastic meningiomas. Am J Pathol. 159:2001;661-669.
3. Cai D.X., Banerjee R., Scheithauer B.W., et al. Chromosome 1p and 14q FISH Analysis in Clinicopathologic Subsets of Meningioma diagnostic and Prognostic Implications . J Neuropathol Exp Neurol. 60:2001;628-636.
4. Cushing H., Eisenhardt L. Meningiomas. Their classification, regional behaviour, life history, and surgical end results. 1938;Charles C. Thomas, Springfield, IL.
5. Gutmann D.H., Donahoe J., Perry A., et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningioma. Hum Mol Genet. 9:2000;1495-1500.
6. Gutmann D.H., Giovannini M. Mouse models of neurofibromatosis 1 and 2. Neoplasia. 4:2002;279-290.
7. Louis D.N., Scheithauer B.W., Budka H., von Deimling A., Kepes J.J. Meningiomas. Kleihues P., Cavenee W.K. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. 2000;176-184 IARC Press, Lyon.
8. Perry A., Banerjee R., Lohse C.M., Kleinschmidt-DeMasters B.K., Scheithauer B.W. A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas. Brain Pathol. 12:2002;183-190.
9. Perry A., Giannini C., Raghavan R., et al. Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas a clinicopathologic study of 53 cases . J Neuropathol Exp Neurol. 60:2001;994-1003.
10. Perry A., Scheithauer B.W., Stafford S.L., Lohse C.M., Wollan P.C. "Malignancy" in meningiomas a clinicopathologic study of 116 patients . Cancer. 85:1999;2046-2056.
11. Perry A., Stafford S.L., Scheithauer B.W., Suman V.J., Lohse C.M. Meningioma grading an analysis of histologic parameters . Am J Surg Pathol. 21:1997;1455-1465.
12. Ruttledge M.H., Sarrazin J., Rangaratnam S., et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet. 6:1994;180-184.
13. Watson M.A., Gutmann D.H., Peterson K., et al. Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol. 161:2002;665-672.
14. Weber R.G., Boström J., Wolter M., et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas Toward a genetic model of meningioma progression . Proc Natl Acad Sci USA. 94:1997;14719-14724.
15. Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases.